Latham & Watkins LLP represented the underwriters in the transaction. Castle Biosciences, Inc. closed its underwritten public offering of 4,600,000 shares of its common stock, including…
This content is for Standard 1 Year members only. LoginJoin Now
Author: Ambrogio Visconti
…
This content is for Standard 1 Year members only. LoginJoin Now